Advances in Pharmacoepidemiology and Drug Safety

Kumar R

Publications

• Review Article
  Indian Pharmacopoeia Commission's Partners for Promoting Public Health
  Author(s): Kalaiselvan V, Kumar R and Singh GN Kalaiselvan V, Kumar R and Singh GN
  
  In order to promote the awareness and to monitor the adverse drugs reactions, one of the most noteworthy nation-wide programme initiated by IPC on 15th April 2011 under the aegis of Central Drugs Standard Control Organization (CDSCO), is Pharmacovigilance Programme of India (PvPI). IPC is a National Coordination Centre (NCC) for PvPI, meant for protecting the health of the public by assuring medicines safety. PvPI monitors the benefitrisk profile of medicines & generate independent, evidence based recommendations on safety of medicines & support CDSCO for formulating safety related regulatory decisions for medicines. With a view to establish a centre of excellence for pharmacovigilance in India, NCC-PvPI collaborated with the WHO-Uppsala Monitoring Centre (UMC), Sweden & participating in International Drug Monitoring Programme & now become a sig.. View More»
  DOI: 10.4172/2167-1052.1000181

  Abstract PDF